STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALUR
  4. [EFFECT] ALLURION TECHNOLOGIES, INC. SEC Filing

[EFFECT] ALLURION TECHNOLOGIES, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 16, 2026 5:30 P.M.
Form: S-3
CIK: 0001964979
Company Name: ALLURION TECHNOLOGIES, INC.
File Number: 333-292660

Source: View Original Filing on SEC EDGAR

Stock ALUR logo
ALLURION TECHNOLOGIES INC

NYSE:ALUR

ALUR Rankings

#6038 Ranked by Market Cap
N/A Ranked by Dividends

ALUR Latest News

Jan 12, 2026
Allurion Announces Preliminary Fourth Quarter and Full-Year 2025 Results
Nov 25, 2025
Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and GLP-1 Adherence
Nov 20, 2025
New Peer-Reviewed Publication Demonstrates Superior Weight Loss and Improved Body Composition with the Allurion Smart Capsule Combined with Lifestyle Intervention Compared to Lifestyle Intervention Alone
Nov 18, 2025
Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss
Nov 12, 2025
Allurion Reports Third Quarter 2025 Financial Results and Provides Business Update

ALUR Latest SEC Filings

Jan 16, 2026
[424B3] ALLURION TECHNOLOGIES, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 12, 2026
[8-K] ALLURION TECHNOLOGIES, INC. Reports Material Event
Jan 9, 2026
[S-3] ALLURION TECHNOLOGIES, INC. Shelf Registration Statement
Dec 22, 2025
[424B3] ALLURION TECHNOLOGIES, INC. Prospectus Filed Pursuant to Rule 424(b)(3)
Dec 22, 2025
[424B3] ALLURION TECHNOLOGIES, INC. Prospectus Filed Pursuant to Rule 424(b)(3)

ALUR Stock Data

19.65M
11.50M
10.26%
40.98%
1.36%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NATICK